The global robotic angiography systems market is expected to expand at a healthy CAGR of nearly 5% to 6% during the forecast period 2022-2032. The adoption of advanced diagnostics equipments and innovative imaging tools is rapidly increasing across the medical sector, for high precision, accurate, and reliable assessment of the blood flow-related complications inside the human body. This is estimated to create high revenue generation opportunities in the robotic angiography systems market.
| Report Attribute | Details |
| Robotic Angiography Systems Market Projected Growth Rate (2022-2032) | 5% to 6% CAGR |
Angiography is a type of minimally invasive medical imaging technique used to view the insides of distinct organs and blood vessels in the human body. With increasing advancements in imaging technology and growing integration of automation, healthcare infrastructures are increasing adoption of novel robotic imaging solutions for angiography. This is projected to augment the demand for robotic angiography systems in the global market.
Due to increasing obesity, growing bad eating habits, and rising consumption of alcohol, there is a significant rise in the burden of heart and kidney-related disorders across the globe. For instance, according to a study by the National Institute of Diabetes and Digestive and Kidney Diseases, nearly 37 million people, or more than 1 out of 7 adults in the U.S. are reported to be suffering from chronic kidney diseases.
Robotic angiography systems are increasingly used for visualizing the blood vessels in the heart and kidneys for the accurate identification and assessment of the complications, by declining the risk of human errors. Hence, growing burden of such diseases is anticipated to drive the sales in the global market.
Although there are numerous benefits associated with the use of robotic angiography systems, some of the factors such as high risk of radiation exposure, injury due to catheterized artery, and unsuitability for critically ill patients among others are hampering the sales in the global market.
Also, high cost of the angiography procedures, extravagant initial cost of robotic angiography systems, and limited reimbursement for angiographic surgeries are further impeding the growth in the market.
North America is forecast to emerge as the most lucrative market for robotic angiography systems between 2022 and 2032, as per a study by FMI.
As the burden of conditions related to blood vessels, brain, heart, kidney, and others continues to increase along with growing adoption of high precision imaging solutions, there is a rise in demand for robotic angiography systems. Hence, leading manufacturers are focusing on launching new products to address the growing demand.
For instance, in 2021, GE Healthcare, an American manufacturer of diagnostic imaging solutions announced launching a new version of its robotic angiography systems, Allia IGS 7, which used artificial intelligence (AI) optimized imaging settings. A multiplicity of such new product launching is anticipated to accelerate the sales of robotic angiography systems in the North America market.
Europe is expected to register growth at a steady CAGR in the global robotic angiography systems market during the forecast period 2022-2032, reveals Future Market Insights.
Over the past couple of years, there a swift increase in the incidence of cardiovascular diseases such as heart attack, arrhythmias, deep vein thrombosis, stroke, and others worldwide, due to the increasing smoking, tobacco & opioid use, alcohol abuse, and others.
As robotic angiography systems are used to visualize and identify narrow or blocked arteries, and malformed veins or arteries that result in limiting the blood flow to the heart, increasing prevalence of such ailments is projected to favor the growth in the Europe market.
Some of the key players in the robotic angiography systems market are GE Healthcare, KUKA AG, Philips Healthcare, Siemens Healthcare Private Limited, Corindus, Inc., Shimadzu Medical Systems, and others.
Attributed to the growing emphasis on introducing novel products and adopting strategies such as collaboration, agreement, and acquisition by leading companies, the market for robotic angiography systems is highly competitive.
| Report Attribute | Details |
| Growth Rate | CAGR of 5% to 6% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Countries Covered |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Technology:
By Application:
By Indication:
By End User:
By Region:
FMI projects the sales of robotic angiography systems in the market is expected to rise at 5% to 6% value CAGR by 2032
The global robotic angiography systems market is expected to be dominated by North America over the forecast period 2022-2032.
GE Healthcare, KUKA AG, Siemens Healthcare Private Limited, Corindus, Inc., Philips Healthcare, Shimadzu Medical Systems, others are some of the leading players in the prominent robotic angiography systems market.
Explore Similar Insights
Robotic Angiography Systems Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
